Platelet-Vessel Wall Interaction: from the Bedside to Molecules

• References

• 1 Glanzmann E. Hereditare hämorragische Thrombasthenie. Ein Beitrag zur Pathologie der Blutplattchen Jahr Kinderh 1918; 88: 113-141
• 2 v.Willebrand EA. Hereditar pseudohemofili. Finska Lakaresallskapets Handlingar 1926; 68: 87-112
• 3 Bernard J, and Soulier JP. Sur une nouvelle variete de dystrophie thrombocytaire hemorragipare congenitale. Sem Hop Paris 1948; 24: 3217-3223
• 4 Nilsson IM, Blomback M. Jorpes and Johansson S.A. v Willebrand’s disease and its correction with human plasma fraction. IO Acta Med Scand 1957; 159: 179-179
• 5 Comu P, Larrieu MJ, Caen J, Bernard J. Transfusion studies in von Willebrand’s disease: Effect on bleeding time and Factor VIII. Brit J Haemat 1963; 9: 189-202
• 6 Howard MA, Firkin BG. Ristocetin: a new tool in the investigation of platelet aggregation. Thromb Diath Haemorrhag 1972; 26: 362-362
• 7 Caen J, Levy-Toledano S. Interaction between platelets an von Willebrand factor provides a new scheme for primary hemostasis. Nature 1972; 244: 159-160
• 8 Gaarder A, Jonsen JR, Laland S, Hellem A, Owren P. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; 192: 531-533
• 9 Caen J, Cousin C. Le trouble d’adhesivite “in vivo” des plaquettes dans la maladie de Willebrand et les thrombasthenies de Glanzmann. Essai d’interpretation. Nouv Rev Fr Hemat 1962; 2: 685-694
• 10 Caen JP. Glanzmann thrombasthenia. In: Clinics in Hematology-Platelet disorders O’Brien JR. Ed. Publish. W.B. Saunders C°; Ltd. London.: 1972. 1. 383-392
• 11 Nurden AT, Caen JP. An abnormal glycoprotein pattern in 3 cases of Glanzmann thrombasthenia. Brit J Haemat 1974; 28: 253-260
• 12 Nurden AT, Caen JP. Specific roles for platelet surface glycoproteins in platelet function. Nature 1975; 255: 720-722
• 13 Caen JP, Michel H, Bodevin E, Levy-Toledano S. Adhesion and aggregation of human platelet to rabbit subendothelium. A new approach for investigation: specific antibodies. Experientia 1977; 33: 91-93
• 14 Fauvel F, Grant MC, Legrand Y, Souchon H, Tobelem G, Jackson DS, Caen JP. Interaction of blood platelets with microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor. Proc Natl Acad Sci. USA 1983; 80: 551-554
• 15 Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet membrane glycoprotein Ilb-IIIa complex. Blood 1988; 71: 831-843
• 16 Bray PF. Inherited diseases of platelet glycoproteins: Considerations for rapid molecular characterisation. Thromb Haemost 1994; 72: 492-502
• 17 Newman PJ, Seligsohn U, Lyman S, Coller BS. The molecular genetic basis of Glanzmann thrombasthenia in the Iraqi-Jewish and Arab populations in Israel. Proc Natl Acad Sci USA 1991; 88: 3160-3164
• 18 Loftus JC, O’Toole TE, Plow EF, Glass A, Frelinger AL, Ginsberg MH. Apj integrin. Science 1990; 249: 915-918
• 19 Djaffar L, Rosa JP. A second case of variant of Glanzmann’s thrombasthenia due substitution of platelet GPIIIa (integrin B3) Arg214 by Tip. Hum Mol Genetics 1993; 2: 2179-2180
• 20 Djaffar I, Caen JP, Rosa JP. A large alteration in the human platelet glycoprotein Ilia (integrin 63) gene associated with Glanzmann’s thrombasthenia. Hum Mol Genetics 1993; 2: 2183-2185
• 21 Chen Y, Djaffar I, Pidard D, Steiner B, Cieutat AM, Caen JP, Rosa JP. Ser-752-> Pro mutation in the cytoplasmic domain of integrin b₃ subunit and defective activation of platelet integrin x_r[bp₃ (glycoprotein Ilb-IIIa) in a variant of Glanzmann. thrombasthenia Proc Natl Acad Sci USA 1992; 89: 10169-10173
• 22 Chen Y, O’Toole TE, Ylanne J, Rosa JP, Ginsberg MH. A point mutation in the integrin 63 cytoplasmic domain (Ser-752->P) impairs bidirectional signaling through cx_IIbp₃ (platelet glycoprotein Ilb-IIIa). Blood 1994; 84: 1857-1865
• 23 Lanza F, Stierle A, Fournier D, Morales M, Andre G, Nurden AT, Cazenave JP. A new variant of Glanzmann’s thrombasthenia. Platelets with functionally defective glycoprotein Ilb-IIIa complexes and a glycoprotein Ilia ²¹⁴Arg-> ²¹⁴ Trp mutation. J din Invest 1992; 89: 1995-2004
• 24 Bajt ML, Ginsberg MH, Frelinger AL, Bemdt MC, Loftus JC. A spontaneous mutation of integrin (platelet glycoprotein Ilb-IIIa) helps define a ligand binding site. J Biol Chem 1992; 267: 3789-3794
• 25 Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coagulation Fibrinolysis. 1994; 5: 97-119
• 26 de Marco L, Mazzucato M, Fabris F, de Roia D, Coser P, Girolami A, Vicente V, Ruggeri ZM. Variant Bernard Soulier syndrome type Bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib/IX complex. J din Invest 1990; 86: 25-31
• 27 Ware J, Russel S, Marchese P, Murata M, Mazzucato M, de Marco L, Ruggeri ZM. Point mutation in aleucine-rich repeat of platelet glycoprotein Iba resulting in the Bernard Soulier syndrome. J Clin Invest 1993; 92: 1213-1220
• 28 Ware J, Russel S, Vincente V, Scharf RE, Tomer A, McMillan R, Ruggeri ZM. Non-sense mutation in the glycoprotein Iba coding sequence associated with Bernard Soulier syndrome. Proc Natl Acad Sci USA 1990; 87: 2026-2030
• 29 Miller JL, Lyle VA, Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Iba leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard Soulier syndrome. Blood 1992; 79: 439-446
• 30 Simsek S, Admiraal LG, Modderman PW, van der Schoot EC, von dem Borne AE G Kr. Identification of a homozygous single base pair deletion in the gene coding for the human glycoprotein Iba causing Bernard Soulier syndrome. Thromb Haemostasis 1994; 72: 444-449
• 31 Arai M, Yamamoto N, Akamatsu N, Susuki H, Yamaguchi A, Nishida Y, Fukutake K, Tanoue K. Substantial expression of glycoprotein IX and V on the platelet surface from a patient with Bemard-Soulier syndrome. Br J Haemat 1994; 87: 185-188
• 32 de la Salle C, Baas MJ, Lanza F, Schwartz A, Hanau D, Chevalier J, Gachet C, Briquel ME, Cazenave JP. A three base deletion removing a leucine residue in a leucine-rich repeat of platelet glycoprotein Iba associated with a variant of Bemard-Soulier syndrome (Nancy I). Br J Hemat. 1995 89. (in press)
• 33 Wright SD, Michaelides K, Johnson DJD, West NC, Tuddenham EG D. Double heterozygosity for mutations in the platelet glycoprotein DC gene in three siblings with Bemard-Soulier syndrome. Blood 1993; 81: 2339-2347
• 34 Clemetson JM, Kyrle PA, Brenner B, Clemetson K. Variant Bemard-Soulier syndrome associated with a homozygous mutation in the leucine-rich domain of glycoprotein IX. Blood 1994; 84: 1124-1131
• 35 Miller JL, Cunningham D, Lyle VA, Finch CS. Mutation in the gene encoding the a chain of platelet glycoprotein lb in platelet-type von Willebrand disease. Proc Natl Acad Sci USA 1991; 88: 4761-4765
• 36 Russel SD, Roth GJ. Pseudo von Willebrand disease: a mutation in the platelet glycoprotein Iba gene associated with a hyper active surface receptor. Blood 1993; 81: 1787-1791
• 37 Ruggeri ZM. Structure and function of von Willebrand factor: relationship to von Willebrand’s disease. Mayo Clin. Proc 1991; 66 (08) 847-861
• 38 Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1993; 69: 177-184
• 39 Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-525
• 40 Miller JL, Cisse Thiam M, Drouet L. Reduction in thrombosis formation by PG-1 F(ab')2 an antiguinea pig platelet glycoprotein lb monoclonal antibody. Arterioscl Thromb 1991; 11: 1231-1236
• 41 Azzam K, Garfinkel LI, Bal dit Sollier C, Cisse Thiam M, Drouet L. Antithrombotic effect of recombinant von Willebrand factor, VCL, on nitrogen laser induced thrombus formation in guinea pig mesenteric arteries. Thromb Haemost 1995; 73: 318-323
• 42 Nichols TC, Samama ChM, Bellinger DA, Roussi J, Reddick RL, Bonneau M, Read MS, Bailliart O, Koch GG, Vaiman M, Brinkhous KM, Pignaud G, Sigman JL, Griggs TR, Drouet L. Altered phenotypes of normal and type III von Willebrand disease pigs by bone marrow transplantation: effects on thrombosis and hemostasis. Proc Natl Acad Sci 1995 (in Press).